Stimulating Antimicrobial Stewardship
While fighting COVID-19, we must not neglect the global threat of AMR
Chris Cook | | Opinion
Now that we are seeing the true impact of a pandemic, it is more critical than ever to consider the global threat antimicrobial resistance (AMR) poses to human health.
Viral respiratory infections like COVID-19 predispose patients to coinfections, which lead to increased disease severity and mortality. Studies have already found that a significant number of hospitalized COVID-19 patients develop dangerous secondary bacterial coinfections (1) – and that 50 percent of COVID-19 patients who died had secondary bacterial infections (2).
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.